Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies

Journal of Urology

Volumn 161, Issue 6, 1999, Pages 1826-1830

  McMahon, Chris G ^a   Touma, Kamal ^a  

^a St Lukes Hospital   (Australia)

Author keywords

Antidepressant drugs; Ejaculation; Paroxetine

Indexed keywords

PAROXETINE;

ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; LATENT PERIOD; MALE; ORAL DRUG ADMINISTRATION; PREMATURE EJACULATION; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; TREATMENT OUTCOME;

EID: 0032828104     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68816-7     Document Type: Article

References (23)

1. American Psychiatry Association: Diagnostic and Statistical Manual of Mental Disorders, DSM-IV, 4th ed. Washington, D. C.: American Psychiatric Association, pp. 509-511, 1994.
2. McIntosh, T. K. and Barfield, R. J.: Brain monoaminergic control of male reproductive behaviour. II. Dopamine and the post-ejaculatory refractory period. Behav. Brain Res., 12: 267, 1984.
3. DeVeaugh-Geiss, J., Landau, P. and Katz, R.: Preliminary results from a multicenter trial of chlomipramine in obsessive-compulsive disorder. Psychopharmacol. Bull., 25: 36, 1989.
4. Monteiro, W. O., Noshirvani, H. F., Marks, I. M. and Lelliott, P. T.: Anorgasmia from chlomipramine in obsessive-compulsive disorder: a controlled trial. Brit. J. Psychiat., 151: 107, 1987.
5. Girgis, S. M., El-Haggar, S. and El-Hermouzy, S.: A double blind trial of chlomipramine in premature ejaculation. Andrologia, 14: 364, 1982.
6. Althof, S., Levine, S., Corty, E., Risen, C. and Stern, E.: The role of chlomipramine in the treatment of premature ejaculation. J. Urol., part 2, 151: 345A, abstract 470, 1994.
7. Goodman, R. E.: An assessment of chlomipramine (Anafranil) in the treatment of premature ejaculation. J. Int. Med. Res., suppl., 3: 53, 1980.
8. Patterson, W. M.: Fluoxetine induced sexual dysfunction (Letter to the Editor). J. Clin. Psychiat., 54: 71, 1993.
9. Kara, H., Aydin, S., Agargun, M. Y., Odabas, O. and Yilmaz, Y.: The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J. Urol., 156: 1631, 1996.
10. Crenshaw, R.: Treatment of premature ejaculation with fluoxetine. Presented at American Psychiatric Association Meeting, May 1992.
11. Forster, P. and King, J.: Fluoxetine for premature ejaculation. Amer. J. Psychiat., 151: 1523, 1994.
12. Swartz, D. A.: Sertraline hydrochloride for premature ejaculation. J. Urol., part 2, 151: 345A, abstract 471, 1994.
13. Mendels, J., Camera, A. and Sikes, C.: Sertraline treatment for premature ejaculation. J. Clin. Psychopharmacol., 15: 341, 1995.
14. McMahon, C. G.: Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled cross-over study. J. Urol., 159: 1935, 1998.
15. Waldinger, M. D., Hengeveld, M. W. and Zwinderman, A. H.: Paroxetine treatment of premature ejaculation: a double-blind randomized, placebo-controlled study. Amer. J. Psychiat., 151: 1377, 1994.
16. Waldinger, M. D., Hengeveld, M. W. and Zwinderman, A. H.: Ejaculation-retarding properties of paroxetine in men with primary premature ejaculation: a double-blind, randomized, dose-response study. Brit. J. Urol., 79: 592, 1997.
17. Ludovico, G. M., Corvasce, A., Pagliarulo, G., Cirillo-Marucco, E., Marano, A. and Pagliarulo, A.: Paroxetine in the treatment of premature ejaculation. Brit. J. Urol., 77: 881, 1996.
18. Giammusso, B., Morgia, G., Spampinato, A. and Motta, M.: Paroxetine in the treatment of premature ejaculation. Arch. Ital. Urol. Androl., 69: 11, 1997.
19. McMahon, C. G.: Treatment of premature ejaculation with paroxetine hydrochloride. Int. J. Impotence Res., suppl., 9: S38, abstract 36.
20. Hiemke, C.: Paroxetine: pharmacokinetics and pharmacodynamics. Fortschritte der Neurologie-Psychiatrie., suppl., 62: 2, 1994.
21. Bloomer, J. C., Woods, F. R., Haddock, R. E., Lennard, M. S. and Tucker, G. T.: The role of cytochrome P450 2D6 in the metabolism of paroxetine by human liver microsomes. Brit. J. Clin. Pharmacol., 33: 531, 1992.
22. Preskorn, S. H.: Pharmacokinetics of anti-depressants: why and how they are relevant to treatment. J. Clin. Psychiat., suppl., 54: 14, 1993.
23. Kaye, C. M., Haddock, R. E., Langley, P. F., Mellows, G., Tasker, T. C., Zussman, B. D. and Greb, W. H.: A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiat. Scand., suppl., 80: 60, 1991.